Study Shows Mepolizumab to Be a Safe and Effective Long-Term Treatment Option for Severe Asthma

The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly. [PRESS RELEASE] Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control New study